Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Incannex Healthcare Inc. - Common Stock (NQ: IXHL ) 2.250 -0.090 (-3.85%) Streaming Delayed Price Updated: 3:59 PM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Incannex Healthcare Inc. - Common Stock < Previous 1 2 3 4 5 6 7 8 Next > Psychedelic Drug Stocks Dragged Down By 83% Collapse In SEEL Stock Price September 24, 2023 With the 82.6% collapse of Seelos Therapeutics (SEEL) last week, the 6 psychedelic-compound-based research & development stocks in our Psychedelic Drug Stocks Index declined by 13.0%, on average, and... Via Talk Markets Psyched: MDMA Trials For PTSD, Congressional Amendments, Scotland's Consumption Site & More September 18, 2023 Treating PTSD With MDMA Therapy: New Results From MAPS Clinical Study, FDA Submission Next Via Benzinga Exposures Product Safety 4 Of The 6 Largest Psychedelic Compound-Based R & D Stocks Had A Good Week September 17, 2023 4 of the 6 psychedelic-compound-based research & development stocks in our Psychedelic Drug Stocks Index were up in price last week versus only 1 the previous week. The Index was up 2.4% for the week... Via Talk Markets Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More September 11, 2023 Single Psilocybin Dose 'Significantly' Reduces Major Depression Symptoms, An AI Predictive Model, And UK’s Struggle For Reclassification Via Benzinga Topics Artificial Intelligence Exposures Artificial Intelligence 6 Largest Psychedelic Compound-Based R & D Stocks In Decline September 10, 2023 The 6 psychedelic compound-based research & development stocks in our Psychedelic Drug Stocks Index were down 2.6%, on average, this week and are now only up 6.5% YTD. Via Talk Markets 6 Largest Psychedelic Compound-Based R & D Stocks Up 4%, On Average, Last Week September 05, 2023 The 6 psychedelic compound-based research & development stocks in our munKNEE Psychedelic Drug Stocks Index were UP 3.9%, on average, last week and are now only UP 9.4% YTD. Via Talk Markets Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More September 05, 2023 Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety Via Benzinga August Recap: Largest Psychedelic Compound-Based R & D Stocks Down 15% September 02, 2023 The 6 psychedelic compound-based research & development stocks in our Psychedelic Drug Stocks Index were down 15.0%, on average, in August and are now only up 5.3% YTD. Via Talk Markets Psyched: Psilocybin For Gambling Addiction, Ex-NHL Player's Retreat, Fellini's LSD Creativity, Surveys, Financing & More August 28, 2023 Psilocybin Therapy Trials: Gambling Addiction Study, Opioid Pain & Alcohol Addiction Trials Via Benzinga 6 Largest Psychedelic Compound-Based R&D Stocks Continued Downwards, On Average, This Week August 25, 2023 Only 2 of the 6 psychedelic compound-based research & development stocks in our Psychedelic Drug Stocks Index were up this week. Via Talk Markets Incannex preparing psilocybin therapy FDA IND application August 24, 2023 Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) chief medical officer Dr Mark Bleakley tells Proactive the company is preparing an application to gain key regulatory approval to begin clinical trials in... Via TheNewswire.com Exposures Product Safety Incannex preparing psilocybin therapy FDA IND application August 24, 2023 --News Direct-- Via News Direct Exposures Product Safety Cannabis Stock Gainers And Losers From August 24, 2023 August 24, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Incannex To Prepare FDA IND Application For Psilocybin-Assisted Psychedelic Psychotherapy August 24, 2023 Psychennex Pty Ltd, a subsidiary of Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL) has commenced preparations of an investigational new drug (‘IND’) application to the U.S. Via Benzinga Exposures Product Safety Incannex full steam ahead towards sleep apnoea trial August 23, 2023 Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) chief medical officer Dr Mark Bleakley speaks with Proactive after the company received clearance from the US Food and Drug Administration (FDA) to begin... Via TheNewswire.com Topics Cannabis Exposures Cannabis Product Safety Incannex full steam ahead towards sleep apnoea trial August 23, 2023 --News Direct-- Via News Direct Topics Cannabis Exposures Cannabis Product Safety FDA Approves Clinical Trial Of Incannex's Dronabinol-Based Drug For Obstructive Sleep Apnea August 22, 2023 Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL) has received approval from the US Food and Drug Administration to conduct the company’s investigational new drug (&ls Via Benzinga Exposures Product Safety Psyched: Fed Study On Psychedelics, Janet Yellen's Magic Mushrooms, Financing Deals & Quarterly Reports August 21, 2023 Cannabis, Psychedelics Use And Binge Drinking At All-Time High Among Adults, Teens Remain Stable, Fed Study Finds Via Benzinga Topics Cannabis Economy Exposures Cannabis Interest Rates Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023 August 21, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Largest Psychedelic Compound-Based R&D Stocks Continue Downward Trend August 20, 2023 The 6 psychedelic compound-based research & development stocks in our munKNEE Psychedelic Drug Stocks Index were down an average of 6% last week and are now down 17.2% MTD. We take a look at them in... Via Talk Markets 12 Health Care Stocks Moving In Thursday's After-Market Session August 17, 2023 Via Benzinga Bullish Thursday For Marijuana Stocks - EVIO, Tetra Bio Pharma Among Top Gainers August 17, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Cannabis Stock Gainers And Losers From August 16, 2023 August 16, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More August 14, 2023 First Ever Professional Practice Guidelines For Psychedelic-Assisted Therapy Published Via Benzinga Cannabis Stock Gainers And Losers From August 14, 2023 August 14, 2023 Via Benzinga Topics Cannabis Exposures Cannabis So Far, August Isn't Kind To 4 Of 6 Constituents In Our Psychedelic Drug Stocks Index August 13, 2023 The 6 psychedelic compound-based research & development stocks in our munKNEE Psychedelic Drug Stocks Index are down an average of 11.9% so far in August but are still up YTD. Via Talk Markets Cannabis Stock Gainers And Losers From August 11, 2023 August 11, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Clarion Clinics Begins Accepting Registrations For Psychedelic Treatment Interest August 08, 2023 Clarion Clinics Group Pty Ltd, a subsidiary of Incannex Healthcare Ltd (NASDAQ: IXHL) (ASX:IHL) is now accepting direct registration of interest in treatment from potential clients via its website... Via Benzinga Cannabis Stock Movers For August 10, 2023 August 10, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Bearish Monday For Marijuana Stocks - EVIO, Item 9 Labs Among Top Gainers August 07, 2023 Via Benzinga < Previous 1 2 3 4 5 6 7 8 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.